发明名称 |
Novel interferon for the treatment of multiple sclerosis |
摘要 |
This invention relates to novel nucleic acids and polypeptide sequences, which code for an interferon-beta-2 ("IFN-beta2"). A pharmaceutical composition, which comprises a pharmaceutically acceptable excipient and a therapeutically effective amount of a human IFN-beta2 polypeptide, biologically-active fragment thereof, or biologically-active derivative thereof, is useful in treating multiple sclerosis in humans.
|
申请公布号 |
US2002025304(A1) |
申请公布日期 |
2002.02.28 |
申请号 |
US20010881050 |
申请日期 |
2001.06.15 |
申请人 |
CROZE EDWARD M.;FAULDS DARYL;WAGNER T. CHARIS |
发明人 |
CROZE EDWARD M.;FAULDS DARYL;WAGNER T. CHARIS |
分类号 |
A61K38/00;A61K38/21;A61P19/02;A61P25/00;A61P25/28;A61P29/00;A61P31/12;A61P35/00;A61P37/02;A61P43/00;C07K14/555;C07K14/565;(IPC1-7):A61K38/21 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|